Sfoglia per Autore
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis
2016-01-01 Passiglia, F; Galvano, A; Rizzo, S; Listì, A; Barraco, N; Insalaco, L; Bronte, E; Alessi, I; Guarini, A; Terruso, L; Castellana, L; Perez, A; Massihnia, D; Di Piazza, F; Calò, V; Castiglia, M; Bazan, V; Russo, A
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines
2016-01-01 Perez, A; Castiglia, M; Passiglia, F; Barraco, N; Cangemi, A; Fanale, D; Listì, A; Massihnia, D; Di Piazza, F; Vieni, S; Calò, V; Rizzo, S; Incorvaia; L; Bazan, V; Russo, A
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis
2016-01-01 Passiglia, F.; Bronte, G.; Bazan, V.; Galvano, A.; Vincenzi, B.; Russo, A.
Nintedanib in NSCLC: Evidence to date and place in therapy
2016-01-01 Bronte, G.; Passiglia, F.; Galvano, A.; Barraco, N.; Listì, A.; Castiglia, M.; Rizzo, S.; Fiorentino, E.; Bazan, V.; Russo, A.
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis
2016-01-01 Passiglia, F.; Bronte, G.; Bazan, V.; Natoli, C.; Rizzo, S.; Galvano, A.; Listì, A.; Cicero, G.; Rolfo, C.; Santini, D.; Russo, A.
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
2016-01-01 Bronte, G.; Franchina, T.; Alù, M.; Sortino, G.; Celesia, C.; Passiglia, F.; Savio, G.; Laudani, A.; Russo, A.; Picone, A.; Rizzo, S.; De Tursi, M.; Gambale, E.; Bazan, V.; Natoli, C.; Blasi, L.; Adamo, V.; Russo, A.
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer
2016-01-01 Passiglia, F; Caparica,R; Giovannetti, E; Giallombardo, M; Listi, A; Diana, P; Cirrincione, G; Caglevic, C; Raez, LE; Russo, A; Rolfo C
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?
2016-01-01 Bronte, G.; Incorvaia, L.; Rizzo, S.; Passiglia, F.; Galvano, A.; Rizzo, F.; Rolfo, C.; Fanale, D.; Listì, A.; Natoli, C.; Bazan, V.; Russo, A.
Anti-angiogenic drugs for second-line treatment of NSCLC patients: Just new pawns on the chessboard?
2016-01-01 Bronte, Giuseppe; Passiglia, Francesco; Galvano, Antonio; Russo, Antonio*
Multisciplinary management of patients with liver metastasis from colorectal cancer
2016-01-01 De Greef, K.; Rolfo, C.; Russo, A.; Chapelle, T.; Bronte, G.; Passiglia, F.; Coelho, A.; Papadimitriou, K.; Peeters, M.
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC)
2017-01-01 Rolfo, C.; Castiglia, M.; Perez, A.; Reclusa, P.; Pauwels, P.; Sober, L.; Passiglia, F.; Russo, A.
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib
2017-01-01 Corrales, L.; Nogueira, A.; Passiglia, F.; Listi', A.; Caglevic, C.; Giallombardo, M.; Raez, L.; Santos, E.; Rolfo, C.
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab
2017-01-01 Passiglia, F.; Perez, A.; Listi', A.; Castiglia, M.; Musso, E.; Ancona, C.; Rizzo, S.; Alù, M.; Blasi, L.; Russo, A.
EGFR inhibition in NSCLC: New findings…. and opened questions?
2017-01-01 Passiglia, F.; Listì, A.; Castiglia, M.; Perez, A.; Rizzo, S.; Bazan, V.; Russo, A.
Upfront radiation versus EGFR-TKI: Which is the best approach for EGFR-mutated NSCLC patients with brain metastasis?
2017-01-01 Passiglia, Francesco; Rolfo, Christian*
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway
2017-01-01 LA PAGLIA, L.; Listã¬, A.; Caruso, S.; Amodeo, V.; Passiglia, F.; Bazan, V.; Fanale, D.
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma
2017-01-01 Massihnia D.; Funel N.; Leon L.; Castiglia M.; Perez A.; Barraco N.; Listi A.; Galvano A.; Passiglia F.; Guarini A.; Calo V.; Rizzo S.; Castellana L.; Giovannetti E.; Russo A.
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials
2017-01-01 Rizzo, Sergio; Galvano, Antonio; Pantano, Francesco; Iuliani, Michele; Vincenzi, Bruno; Passiglia, Francesco; Spoto, Silvia; Tonini, Giuseppe; Bazan, Viviana; Russo, Antonio*; Santini, Daniele
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors
2017-01-01 Incorvaia, L.; Passiglia, F.; Rizzo, S.; Galvano, A.; Listì, A.; Barraco, N.; Maragliano, R.; Calò, V.; Natoli, C.; Ciaccio, M.; Bazan, V.; Russo, A.
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis
2018-01-01 Passiglia, Francesco; Rizzo, Sergio; Di Maio, Massimo; Galvano, Antonio; Badalamenti, Giuseppe; Listì, Angela; Gulotta, Leonardo; Castiglia, Marta; Fulfaro, Fabio; Bazan, Viviana; Russo, Antonio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile